
Hongyun Bio
红云生物
Hongyun Bio
Biotech/Healthcare
Hongyun Biotech is a biotechnology company focused on developing new drugs against targets associated with tumor drug resistance. By leveraging research platforms at leading domestic research institutions, it seeks to address tumor resistance and develop innovative drugs protected by global patents.
Latest round: Series B Extension (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-05-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.